A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Study ID
- NCT07749768
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Ulcerative Colitis (UC)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- ONO-6414 — DRUGAdministered orally
- Placebo — DRUGAdministered orally
Study Details
A study to investigate the safety, tolerability, and pharmacokinetics (PK) of ONO-6414 orally in healthy adult participants and in patients with active ulcerative colitis (UC).
Key Dates
- First listed
- Aug 6, 2026
- Start date
- Sep 30, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: ONO-6414: Single ascending doseSingle ascending dose: Participants will receive a single dose of ONO-6414 orally on Day 1.
- Experimental: ONO-6414: Multiple ascending doseMultiple ascending dose: Participants will receive ONO-6414 orally for 7 consecutive days.
- Experimental: ONO-6414: Single doseSingle dose: Participants will receive a single dose of ONO-6414 orally on Day 1.
Primary Outcome Measure
Safety and tolerability: Number of Participants with Adverse Events (AEs) [ Time Frame: Up to 168 hours post-dose ]
Central Contacts
- North America Clinical Trial Support Desk+18665877745(Toll-Free)
- International Clinical Trial Support Desk+17162141777(Standard)
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Syneos Health Miami | Miami | Florida | 33136 | - |
Find similar trials in Miami, FL
By research site
Related Studies
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisPHASE1/PHASE2 · Recruiting · Xencor, Inc. · Scottsdale, Arizona
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel DiseasePHASE2 · Recruiting · Mirador Therapeutics, Inc. · Birmingham, Alabama
- Zymfentra (Infliximab-dyyb) REal World Cohort STudyRecruiting · University of North Carolina, Chapel Hill · New Haven, Connecticut
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisPHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona